journal
manag
compet
imit
pharmaceut
industri
analysi
relationship
firm
perform
donna
mari
de
caroli
manag
depart
lebow
colleg
busi
drexel
univers
chestnut
st
philadelphia
pa
usa
receiv
march
receiv
revis
form
may
accept
februari
two
research
question
address
articl
first
technolog
compet
enhanc
perform
second
competitor
imit
knowledg
hurt
perform
relationship
technolog
compet
imit
perform
basic
premis
resourcebas
view
yet
littl
empir
test
measur
technolog
compet
imit
develop
variabl
togeth
measur
market
regulatori
compet
test
impact
perform
pharmaceut
industri
imit
neg
impact
account
marketbas
perform
measur
contrari
expect
technolog
compet
invers
relat
marketbas
perform
measur
posit
relat
account
measur
research
manageri
implic
discuss
elsevi
scienc
inc
right
reserv
come
core
compet
get
train
walk
next
station
reboard
hamel
quot
articl
prahalad
hamel
succinctli
allegor
relationship
organiz
knowledg
core
compet
core
compet
embodi
organiz
knowledg
built
time
easili
imit
leonardbarton
prahalad
hamel
yield
competit
advantag
core
compet
repres
accumul
knowledg
organ
learn
actual
learn
compet
deploy
compet
tel
fax
email
address
decarold
drexeledu
dm
de
caroli
see
front
matter
elsevi
scienc
inc
right
reserv
pii
dm
de
caroli
journal
manag
strategi
compet
typic
embed
organ
acquir
differ
compet
entail
invest
term
resourc
capit
peopl
manageri
virtual
imposs
next
particularli
true
respect
whose
compet
technolog
base
compet
basi
technolog
advantag
oppos
compet
basi
market
adept
distribut
access
ownership
natur
resourc
develop
sustain
technolog
compet
import
continu
innov
mani
recent
perspect
behavior
resourcebas
view
barney
wernerfelt
dynam
capabl
teec
pisano
shuen
knowledgebas
view
kogut
zander
suggest
compet
stock
knowledg
de
caroli
deed
dierickx
cool
lev
sougianni
accumul
time
competitor
replic
sourc
competit
advantag
barney
dierickx
cool
reed
defillippi
wernerfelt
relat
stream
literatur
propos
core
compet
becom
core
rigid
leonardbarton
core
rigid
opposit
core
compet
strength
evolv
weak
technolog
compet
may
becom
liabil
prevent
expand
outsid
particular
knowledg
trajectori
sustain
competit
advantag
core
rigid
prevent
new
compet
develop
maintain
right
balanc
compet
core
compet
yield
competit
advantag
must
competitor
imit
barney
stress
imit
import
concept
emerg
resourcebas
view
imit
explain
competit
advantag
equilibrium
new
resourcebas
view
barney
claim
empir
assert
deriv
concept
like
among
import
come
resourcebas
barney
howev
littl
empir
research
construct
imit
articl
investig
two
relat
research
question
motiv
resourcebas
view
first
technolog
compet
make
differ
perform
second
competitor
imit
technolog
compet
hurt
given
perform
perform
even
technolog
intens
industri
reli
sole
technolog
expertis
compet
area
market
gener
manag
human
resourc
manag
deal
effect
extern
stakehold
govern
entiti
may
critic
competit
advantag
prahalad
hamel
address
question
hypothes
develop
base
resourcebas
view
relationship
compet
imit
perform
test
pharmaceut
industri
articl
make
sever
contribut
grow
literatur
compet
resourcebas
view
first
address
gap
previou
studi
articl
investig
impact
three
differ
type
compet
perform
extens
previou
empir
work
recent
suggest
lev
sougianni
call
examin
perform
implic
variou
asset
market
relat
compet
second
paper
develop
measur
technolog
compet
captur
build
prior
knowledg
add
grow
literatur
dm
de
caroli
journal
manag
measur
stock
knowledg
see
exampl
cockburn
grilich
hall
jaff
trajtenberg
lev
sougianni
third
although
concept
imit
central
resourcebas
perspect
review
empir
literatur
area
reveal
construct
operation
relationship
perform
assess
fourth
empir
examin
impact
compet
account
marketbas
measur
perform
address
gap
resourcebas
literatur
final
empir
analysi
base
longitudin
data
type
dynam
research
wherein
condit
compet
develop
one
period
implic
subsequ
period
appropri
examin
resourcebas
theori
barney
articl
begin
brief
exposit
role
compet
imit
context
pharmaceut
industri
follow
develop
model
hypothesi
follow
section
describ
methodolog
data
construct
variabl
paper
turn
descript
result
close
discuss
strateg
implic
manag
suggest
futur
research
compet
competit
advantag
term
use
manag
literatur
gener
convey
notion
possess
degre
expertis
excel
one
particular
area
compar
competitor
result
competit
advantag
numer
articl
compet
appear
past
year
particular
nomenclatur
yield
competit
vari
greatli
probabl
term
use
frequent
compet
popular
prahalad
hamel
review
literatur
reveal
sever
concept
emerg
lieu
addit
term
core
compet
compet
commonli
use
term
resourc
strateg
asset
compet
core
compet
capabl
core
capabl
tabl
outlin
term
variou
author
use
tabl
reveal
earli
compet
somewhat
gener
natur
term
evolv
richer
concept
explain
thing
better
tabl
also
illustr
term
use
describ
differ
idea
use
term
compet
distinct
capabl
concur
differ
note
henderson
cockburn
leonardbarton
articl
term
compet
use
denot
local
abil
knowledg
skill
technic
system
may
yield
competit
advantag
review
empir
studi
compet
literatur
reveal
two
gap
literatur
address
articl
first
compet
measur
variou
way
differ
research
compet
operation
survey
instrument
excel
function
area
hitt
ireland
hitt
ireland
palia
hitt
ireland
stadter
snow
hrebiniak
use
measur
intens
ratio
research
develop
sale
advertis
sale
administr
intens
chatterje
wernerfelt
harrison
hitt
hoskisson
ireland
related
among
busi
unit
markid
williamson
robin
wiersema
tabl
overview
relat
compet
manag
literatur
author
selznick
andrew
snow
hrebiniak
wernerfelt
dierickx
cool
prahalad
hamel
barney
grant
resourc
strateg
asset
compet
core
compet
capabl
core
capabl
distinct
thing
organ
well
comparison
competitor
distinct
set
thing
organ
especi
well
comparison
competitor
distinct
aggreg
numer
activ
organ
tend
perform
better
organ
p
anyth
thought
strength
weak
p
could
strateg
asset
stock
asset
nontrad
nonimit
p
asset
capabl
organiz
process
attribut
inform
knowledg
etc
control
enabl
conceiv
implement
strategi
improv
p
input
product
process
resourc
p
collect
learn
organ
coordin
divers
product
skill
integr
multipl
stream
p
capac
team
resourc
perform
task
activ
main
sourc
competit
p
e
c
r
l
j
u
r
n
l
f
n
g
e
e
n
dm
de
caroli
journal
manag
e
l
r
e
g
n
e
l
c
n
h
c
e
l
l
k
e
g
e
l
w
n
k
n
e
b
e
e
g
n
v
h
e
e
g
e
l
w
n
k
e
h
e
v
r
p
n
e
h
u
g
n
e
v
e
p
c
e
u
l
v
n
n
b
c
n
l
l
u
u
e
c
r
u
e
r
e
e
c
r
p
l
n
z
n
g
r
g
n
u
l
p
e
c
p
c
r
p
n
e
e
r
e
c
e
f
f
e
r
e
h
e
l
b
p
c
c
n
l
n
e
n
u
f
r
e
n
e
e
h
r
e
c
n
e
e
p
c
n
e
n
p
c
h
e
g
e
l
w
n
k
n
e
l
b
l
c
l
n
e
n
p
c
e
e
h
e
u
l
b
e
h
r
e
c
n
e
e
p
c
l
r
u
c
e
h
c
r
l
n
e
n
u
f
e
r
p
g
n
v
l
e
l
b
r
p
p
e
c
n
e
e
p
c
l
n
z
n
g
r
r
e
h
w
e
b
h
e
l
b
p
c
p
e
g
n
v
e
v
e
p
c
n
e
c
r
u
e
r
e
z
l
c
e
p
n
e
l
b
r
p
r
p
p
e
c
r
c
e
l
n
r
e
x
e
l
n
r
e
n
e
r
u
g
n
c
e
r
l
p
r
e
r
e
c
n
e
e
p
c
n
e
n
r
v
n
e
g
n
g
n
h
c
l
u
b
e
r
g
e
n
l
b
p
r
f
e
g
n
r
e
h
r
c
g
n
k
l
n
e
l
b
e
e
r
e
c
c
e
p
n
c
u
r
p
r
e
p
c
n
g
n
n
n
p
r
e
u
l
c
e
r
g
e
n
b
e
v
r
e
e
r
c
e
n
u
b
r
n
e
h
w
e
c
n
e
e
p
c
e
n
u
r
p
e
c
v
r
e
e
h
h
p
u
r
g
n
l
u
v
n
e
b
e
l
b
e
v
c
n
e
l
b
n
e
e
n
u
r
l
n
z
n
g
r
e
u
n
c
e
r
f
r
e
p
p
n
e
r
l
u
c
f
f
e
e
h
h
r
c
f
e
l
b
l
v
f
k
c
r
e
k
e
h
c
n
n
r
b
r
n
e
l
p
r
e
h
b
e
l
l
r
n
c
r
e
n
w
e
r
e
l
b
p
n
f
l
u
c
f
e
r
h
e
c
c
e
p
r
e
h
l
e
e
c
e
e
n
r
u
b
k
c
c
n
n
r
e
n
e
h
n
r
u
b
k
c
c
n
n
r
e
n
e
h
p
e
e
g
e
r
n
e
e
l
p
e
h
c
e
l
b
g
n
e
h
e
r
e
c
r
u
e
r
e
u
r
e
e
l
b
g
n
n
p
e
n
r
b
dm
de
caroli
journal
manag
properti
base
vs
knowledgebas
resourc
miller
shamsi
howev
studi
henderson
cockburn
measur
technolog
compet
build
stock
knowledg
second
rel
studi
actual
test
relationship
differ
compet
perform
due
larg
part
oper
issu
exist
mani
compet
repres
differ
level
analysi
moreov
measur
compet
aggreg
level
scholar
use
case
studi
approach
document
link
compet
competit
advantag
colli
leonardbarton
henderson
cockburn
studi
relationship
among
compet
research
product
chatterje
wernerfelt
examin
link
resourc
type
thu
appear
gap
literatur
actual
measur
direct
impact
compet
technolog
regulatori
market
perform
one
purpos
investig
gap
empir
investig
impact
compet
perform
compet
imit
pharmaceut
industri
context
pharmaceut
industri
provid
appropri
domain
studi
sinc
technolog
dynam
industri
discoveri
new
drug
success
commerci
drive
perform
three
type
compet
valuabl
industri
technolog
market
regulatori
bogner
thoma
valu
resourc
determin
context
market
oper
make
valu
compon
resourcebas
view
exogen
determin
barney
priem
butler
technolog
market
regulatori
compet
valuabl
context
pharmaceut
industri
bogner
thoma
cool
schendel
henderson
cockburn
hill
hansen
thoma
technolog
compet
pharmaceut
function
expertis
disciplin
therapeut
area
tradit
knowledg
base
pharmaceut
compani
organ
chemistri
pharmacolog
howev
biotechnolog
affect
technolog
drug
research
capabl
establish
pharmaceut
compani
sinc
knowledg
base
found
genet
molecular
biolog
protein
chemistri
pisano
research
skill
pharmaceut
interpret
rel
variou
therapeut
class
drug
exist
bogner
thoma
pharmaceut
gener
pursu
capabl
particular
therapeut
area
becom
expert
certain
one
factor
contribut
drive
compet
area
preponder
rel
pharmacolog
discoveri
alreadi
made
economist
langreth
tanouy
langreth
becom
pharmaceut
compani
entir
new
drug
mani
breakthrough
medicin
treat
heart
diseas
depress
arthriti
diseas
new
drug
applic
food
drug
administr
fda
peak
subsequ
new
discoveri
becam
harder
dm
de
caroli
journal
manag
evidenc
declin
new
drug
economist
langreth
tanouy
langreth
hand
purs
new
product
one
therapeut
area
enhanc
learn
area
allen
lee
tushman
katz
suggest
technologydriven
environ
intraorganiz
learn
enhanc
research
perform
henderson
cockburn
also
inform
across
boundari
relat
research
product
moreov
strategi
strictli
purs
certain
therapeut
class
could
limit
look
therapeut
area
develop
compet
broader
pipelin
portfolio
potenti
drug
durabl
competit
advantag
partli
function
success
abl
imit
focal
technolog
compet
unsuccess
imit
erod
focal
competit
advantag
howev
technolog
compet
imit
competit
advantag
last
long
certainli
true
mani
industri
perhap
even
critic
pharmaceut
industri
research
develop
cost
industri
somewher
us
us
million
dollar
take
approxim
year
bring
drug
market
medad
news
pharmaceut
compani
patent
new
chemic
entiti
time
discoveri
afford
protect
time
develop
process
complet
fda
approv
achiev
portion
patent
protect
gone
import
implic
innov
industri
patent
grant
knowledg
contain
patent
public
reinforc
fact
learn
must
ongo
imit
eventu
erod
innov
therefor
new
learn
even
area
critic
surviv
effect
deal
fda
anoth
valuabl
resourc
approv
process
new
drug
costli
lengthi
submiss
new
drug
applic
nda
averag
page
review
process
take
anywher
sever
month
sever
year
except
case
prioriti
cancer
aid
treatment
usual
approveddisapprov
within
month
final
pharmaceut
compani
need
effect
market
new
product
success
drug
particularli
categori
high
blood
pressur
drug
depend
well
compani
differenti
drug
particularli
physician
market
share
revenu
particular
drug
depend
larg
part
strong
educ
market
sale
team
thu
context
pharmaceut
provid
rich
arena
examin
effect
technolog
market
regulatori
compet
perform
theoret
model
hypothes
technolog
compet
firm
perform
premis
uniqu
capabl
critic
perform
address
mani
stream
literatur
resourcebas
model
behavior
barney
wernerfelt
organiz
learn
theori
cohen
levinth
fiol
lyle
knowledgebas
perspect
kogut
zander
evolutionari
dm
de
caroli
journal
manag
econom
nelson
winter
dynam
capabl
perspect
teec
et
al
natur
trajectori
knowledg
embed
compet
knowledg
creation
organ
inform
base
commit
belief
holder
nonaka
explan
knowledg
consist
notion
oper
within
certain
technolog
paradigm
dosi
innov
radic
discontinu
sens
make
obsolet
exist
organiz
capabl
tushman
anderson
radic
innov
base
new
scienc
creat
new
market
innov
increment
natur
build
alreadi
exist
knowledg
increment
innov
involv
adapt
enhanc
exist
product
servic
andor
product
process
firm
typic
compet
increment
innov
increas
learn
knowledg
particular
technolog
domin
design
technolog
compet
consist
knowledg
skill
embed
peopl
knowledg
embed
technic
system
leonardbarton
technic
system
manifest
year
accumul
codifi
structur
tacit
knowledg
embodi
peopl
compet
becom
institution
part
organiz
assumpt
guid
strateg
decisionmak
technolog
embed
technic
system
peopl
skill
typic
trace
back
product
servic
domin
logic
betti
prahalad
refer
gener
manag
mindset
pervad
produc
worldview
govern
decisionmak
process
strategi
domin
logic
also
applic
organiz
knowledg
pharmaceut
industri
usual
develop
expertis
therapeut
area
advanc
learn
area
critic
new
drug
discoveri
develop
henderson
cockburn
special
learn
time
reinforc
compet
pattern
interact
bear
success
solut
firm
may
learn
develop
technolog
compet
mani
way
work
particular
technolog
regim
innov
sens
knowledg
combin
creat
improv
product
incorpor
new
function
product
increment
improv
may
duplic
compet
recombin
intern
knowledg
incorpor
either
new
intern
develop
knowledg
newli
acquir
extern
knowledg
exist
product
absorpt
capac
learn
occur
absorpt
extern
knowledg
cohen
levinth
critic
concept
understand
compet
build
firm
may
acquir
extern
knowledg
appli
knowledg
understand
cohen
levinth
also
emphas
absorb
incorpor
new
knowledg
relat
exist
knowledg
base
recombin
intern
capabl
produc
new
knowledg
central
focu
knowledgebas
theori
kogut
zander
creation
technolog
compet
theoret
link
competit
advantag
barney
prahalad
hamel
leonardbarton
particular
mani
studi
address
import
uniqu
technolog
compet
strateg
scienc
technologydriven
industri
dierickx
cool
henderson
cockburn
dm
de
caroli
journal
manag
exist
downsid
build
knowledg
leonardbarton
call
core
rigid
may
result
institution
knowledg
routin
new
concept
technolog
taken
serious
firm
see
compet
valuabl
consid
altern
innov
commerci
possibl
yet
accumul
knowledg
prime
ingredi
technolog
compet
oper
particular
technolog
paradigm
manifest
technolog
compet
abil
becom
enhanc
time
organiz
knowledg
build
stock
knowledg
lead
develop
compet
hypothesi
posit
relationship
technolog
compet
perform
imit
firm
perform
imit
refer
extent
rival
imit
compet
construct
imit
receiv
theoret
attent
scholar
dierickx
cool
reed
defillippi
empir
assert
deriv
concept
barney
like
among
import
eman
resourcebas
view
due
theoret
relationship
sustain
competit
advantag
cours
competit
advantag
sustain
mani
way
differ
condit
reed
defillippi
theoret
empir
undertak
beyond
scope
paper
yet
discuss
role
imit
competit
advantag
well
delin
literatur
central
discuss
competit
advantag
technolog
compet
may
inimit
barney
prahalad
hamel
wernerfelt
may
dissemin
varieti
way
levin
et
al
sever
method
spillov
patent
disclosur
public
technic
meet
convers
employe
compet
hire
employe
rival
revers
engin
product
respect
patent
numer
articl
support
notion
valu
knowledg
contain
patent
spill
cite
patent
theoret
empir
literatur
innov
area
suggest
patent
citat
fact
form
knowledg
spillov
trajtenberg
literatur
also
suggest
highli
cite
patent
innov
vy
imit
idea
carpent
narin
narin
rose
olivastro
trajtenberg
howev
littl
literatur
effect
imit
word
origin
valuabl
innov
imit
case
patent
detriment
effect
competit
advantag
rival
appropri
knowledg
commerci
success
knowledg
pharmaceut
industri
knowledg
spillov
may
research
product
henderson
cockburn
suggest
knowledg
spillov
produc
posit
effect
research
product
knowledg
complementari
howev
rival
research
effort
substitut
would
neg
effect
research
produc
dm
de
caroli
journal
manag
tiviti
moreov
even
though
pharmaceut
compani
licens
patent
receiv
incom
cite
patent
subsequ
patent
abil
captur
gener
legal
mechan
patent
copyright
trade
secret
also
natur
underli
technolog
extent
knowledg
tacit
teec
innov
easili
imit
may
abl
appropri
return
innov
weak
appropri
regim
teec
lessen
chanc
innov
innov
pharmaceut
long
leadtim
patent
new
molecular
entiti
commerci
result
patent
expir
commerci
pisano
moreov
leadtim
may
even
shorter
patent
issu
inform
becom
public
knowledg
rival
opportun
circumv
issu
patent
imit
knowledg
gener
innov
thu
true
knowledg
imit
perform
diminish
hypothesi
imit
knowledg
invers
relationship
perform
market
compet
firm
perform
mention
may
possess
sever
type
compet
conceptu
market
compet
refer
abil
develop
maintain
relationship
custom
abil
use
market
intellig
extern
factor
might
current
futur
custom
need
also
qualiti
channel
relationship
mooreman
slotegraaf
market
compet
propos
import
perform
cool
schendel
current
market
literatur
base
resourcebas
theori
suggest
market
compet
direct
perform
day
hunt
morgan
mooreman
slotegraaf
pharmaceut
industri
deploy
strong
market
capabl
impact
success
new
drug
pharmaceut
compani
reli
highli
train
sale
forc
repres
product
doctor
health
care
system
manag
care
network
pharmaceut
repres
intens
train
knowledg
drug
promot
variou
custom
pharmaceut
compani
track
prescrib
habit
individu
physician
pharmaci
obtain
data
physician
prescrib
particular
drug
strong
market
compet
make
tremend
differ
market
share
drug
type
sever
studi
empir
link
posit
effect
advertis
perform
chauvin
hirschey
jose
nichol
steven
lustgarten
thomadki
morck
shleifer
vishni
manag
literatur
import
resourc
market
innov
skill
close
link
perform
betti
chatterje
wernerfelt
hypothesi
market
compet
posit
relationship
perform
dm
de
caroli
journal
manag
regulatori
compet
firm
perform
barney
suggest
asset
requir
implement
strategi
might
bought
sold
factor
market
dierickx
cool
point
howev
true
asset
consid
exampl
instanc
corpor
reput
dealer
loyalti
abil
deal
government
agenc
dierickx
cool
suggest
asset
nonappropri
nonappropri
deriv
mani
sourc
absenc
properti
right
loyalti
trust
asset
built
accumul
time
firm
engag
consist
pattern
activ
long
period
time
accumul
compet
mention
previous
throughout
drug
develop
process
pharmaceut
compani
must
maintain
constant
commun
fda
oversight
author
clinic
trial
approv
manufactur
drug
pharmaceut
compani
requir
investig
new
drug
ind
applic
fda
must
approv
prior
commenc
clinic
trial
also
need
prepar
nda
fda
approv
manufactur
market
new
drug
pharmaceut
compani
entir
staff
devot
deal
fda
develop
expertis
prepar
complet
requir
document
drug
approv
process
establish
relationship
fda
critic
product
commerci
pharmaceut
industri
cool
schendel
relationship
expertis
commun
fda
attribut
accumul
expertis
area
time
compress
diseconomi
dierickx
cool
tacit
knowledg
complex
asset
reed
defillippi
exist
tremend
human
compon
maintain
success
relationship
extern
agenc
involv
degre
tacit
develop
experi
practic
hard
codifi
character
larg
number
organiz
routin
individu
team
base
experi
regulatori
compet
necessari
maintain
harmoni
relationship
government
agenc
hitt
ireland
thu
addit
technolog
knowledg
market
compet
document
fda
work
relationship
agenc
import
compet
pharmaceut
industri
hypothesi
regulatori
compet
posit
relationship
perform
measur
technolog
compet
imit
technolog
compet
involv
build
stock
knowledg
previou
research
attempt
measur
technolog
compet
case
studi
anecdot
evid
bogner
thoma
colli
grant
leonardbarton
prahalad
hamel
new
measur
technolog
compet
imit
advanc
use
variat
patent
citat
analysi
actual
measur
use
describ
gener
techniqu
patent
citat
analysi
explain
dm
de
caroli
journal
manag
patent
citat
refer
delin
front
page
everi
patent
refer
prior
patent
everi
new
patent
reli
knowledg
develop
past
patent
much
way
advanc
manag
literatur
cite
previou
research
develop
new
invent
patent
invent
cite
prior
front
page
patent
contain
demograph
inform
well
section
titl
section
prior
patent
provid
knowledg
reli
current
patent
list
citat
analysi
involv
select
certain
patent
scrutin
subsequ
patent
assess
mani
time
cite
patent
citat
worthi
indic
technolog
compet
two
reason
first
object
patent
citat
quot
whim
inventor
patent
examin
togeth
inventor
attorney
arriv
list
citat
everi
patent
list
limit
scope
properti
right
patent
owner
protect
law
thu
incent
parti
cite
relev
state
art
campbel
niev
trajtenberg
second
patent
citat
indic
valuabl
technolog
knowledg
patent
highli
cite
one
regard
greater
averag
impact
clearli
patent
citat
analysi
improv
simpl
patent
count
captur
qualiti
patent
studi
carpent
narin
narin
et
al
trajtenberg
empir
establish
valid
patent
citat
analysi
indic
technolog
compet
recent
studi
hall
et
al
citat
weight
patent
stock
highli
correl
market
valu
stock
patent
selfcit
analysi
earlier
work
measur
stock
knowledg
operation
stock
knowledg
patent
data
de
caroli
deed
henderson
cockburn
patent
one
manifest
knowledg
learn
occur
produc
innov
contain
learn
acquir
combin
exist
intern
knowledg
combin
exist
intern
knowledg
new
intern
repres
patent
patent
embodi
stock
accumul
year
also
mani
year
extend
prior
empir
applic
studi
suggest
abil
build
knowledg
manifest
frequenc
cite
invent
activ
issu
patent
present
studi
measur
use
variat
patent
citat
analysi
refer
prior
patent
subsequ
patent
repres
build
knowledg
stock
approach
analog
bibliograph
author
count
indic
frequent
research
natur
social
scienc
quot
research
cite
past
work
build
knowledg
within
particular
area
becom
expert
area
reason
appli
patent
refer
thu
method
use
studi
repres
stock
knowledg
patent
selfcit
analysi
similarli
imit
may
measur
assess
frequent
compani
cite
particular
knowledg
obtain
patent
data
expect
valu
knowledg
dilut
compani
tri
mimic
knowledg
dm
de
caroli
journal
manag
methodolog
addit
reason
discuss
choos
pharmaceut
industri
domain
studi
test
model
test
singl
industri
multipl
point
time
rather
multipl
industri
control
industri
effect
patent
data
obtain
comput
horizon
inc
chi
sampl
consist
pharmaceut
compani
repres
major
global
top
annual
us
pharmaceut
sale
least
one
sampl
year
use
extens
previou
research
compani
abbott
lab
american
home
product
bristol
myer
squibb
eli
lilli
glaxo
johnson
johnson
merck
monsanto
scheringplough
smith
kline
beecham
syntex
upjohn
warner
lambert
measur
descript
measur
use
independ
depend
variabl
given
measur
technolog
compet
imit
deriv
patent
databas
develop
chi
databas
obtain
author
includ
select
inform
patent
patent
citat
pharmaceut
compani
year
technolog
compet
techcomp
variabl
calcul
follow
compani
issu
number
patent
given
year
within
year
issu
date
patent
cite
patent
citat
patent
belong
compani
ratio
xn
measur
use
technolog
compet
imit
imit
similar
selfcit
measur
calcul
follow
compani
issu
number
patent
given
year
within
year
issu
date
patent
cite
patent
citat
patent
compani
ratio
yn
measur
use
imit
market
compet
adsal
rel
advertis
expenditur
use
measur
total
advertis
expenditur
divid
total
sale
given
year
inform
obtain
compustat
previou
studi
util
level
spend
intens
proxi
market
skill
betti
chatterje
wernerfelt
lecraw
regulatori
compet
approv
construct
operation
number
new
drug
per
year
per
pharmaceut
compani
may
develop
reput
deal
effect
fda
expertis
amount
new
drug
approv
per
year
new
drug
categor
type
drug
high
prioriti
drug
use
basi
measur
type
drug
fda
pink
sheet
repres
total
new
chemic
entiti
thu
embodi
culmin
develop
knowledg
research
develop
expenditur
rdsale
research
develop
expenditur
use
proxi
innov
compet
technolog
strength
dm
de
caroli
journal
manag
hill
snell
jensen
assumpt
fund
commit
r
chanc
innov
altern
view
grabowski
vernon
grave
langowitz
mcclean
round
scherer
suggest
increas
r
expenditur
fact
lead
declin
innov
given
inconsist
result
prior
research
effect
research
develop
perform
henderson
cockburn
includ
control
variabl
measur
ratio
research
develop
expenditur
total
sale
data
obtain
compustat
size
asset
size
pharmaceut
compani
measur
total
asset
includ
control
variabl
data
obtain
compustat
total
number
patent
patent
variabl
measur
total
number
patent
grant
pharmaceut
compani
per
year
includ
control
variabl
singl
patent
count
correl
innov
prior
empir
studi
firm
age
age
sorensen
stuart
found
age
implic
innov
activ
found
tendenc
cite
patent
increas
age
studi
one
industri
rel
similar
age
howev
age
includ
control
variabl
acknowledg
effect
found
sorensen
stuart
perform
roa
mkbk
perform
measur
use
return
asset
roa
market
book
valu
mb
sever
reason
use
measur
first
measur
frequent
use
strategi
literatur
previou
research
resourcebas
view
also
empir
examin
measur
function
compet
bierli
chakrabarati
harrison
et
al
markid
williamson
investig
also
part
patentsperform
literatur
span
disciplin
strategi
econom
within
stream
mani
studi
explor
relationship
innov
market
valu
use
patent
data
deng
lev
narin
hausman
hall
grilich
hall
hall
et
al
tradit
literatur
market
book
valu
also
use
perform
measur
market
book
valu
captur
market
valuat
total
asset
tangibl
intang
rel
account
book
valu
asset
market
book
captur
futur
econom
return
wherea
return
asset
captur
current
return
mueller
compustat
sourc
perform
measur
analysi
sinc
data
cover
year
studi
employ
timeseri
cross
section
regress
analysi
particular
techniqu
use
tsc
reg
found
sa
model
investig
consist
observ
unit
sever
time
observ
may
statist
independ
bias
associ
serial
contemporan
correl
residu
heteroskedast
gl
dm
de
caroli
journal
manag
estim
techniqu
park
take
account
three
sourc
bia
assumpt
serial
correl
assum
error
term
within
cross
section
highli
correl
year
year
second
bia
heteroskedast
occur
residu
common
varianc
third
contemporan
correl
park
method
correct
bias
particular
type
timeseri
cross
section
analysi
perform
manag
studi
mizruchi
stearn
stearn
mizruchi
analysi
perform
use
model
lag
independ
depend
variabl
lag
account
lag
effect
compet
imit
activ
perform
conceptu
independ
variabl
repres
stock
compet
similarli
variabl
imit
captur
cumul
imit
technolog
compet
hand
may
also
lag
effect
accumul
compet
affect
perform
futur
period
studi
area
shown
lag
effect
deng
et
al
hausman
et
al
result
concern
patent
citat
analysi
tabl
show
breakdown
citat
within
sampl
outsid
sampl
sampl
includ
total
patent
one
thousand
six
hundr
eight
patent
selfcit
within
group
two
thousand
two
hundr
cite
outsid
sampl
averag
patent
activ
sampl
patent
descript
statist
correl
analysi
present
tabl
techncomp
imit
standard
ttest
perform
check
differ
mean
technolog
compet
imit
test
level
note
citat
begin
declin
last
year
case
citat
made
patent
kept
mind
interpret
regress
result
hall
result
correl
analysi
show
problem
multicollinear
among
independ
variabl
would
expect
posit
correl
asset
patent
suggest
larger
engag
patent
activ
posit
correl
age
asset
impli
older
larger
size
patent
neg
correl
rdsale
suggest
research
develop
dollar
necessarili
result
increas
patent
tabl
breakdown
patent
citat
within
sampl
outsid
sampl
selfcit
cite
other
total
tabl
descript
statist
correl
analysi
mean
sd
variabl
roa
mkbk
techcomp
imit
adsal
approv
rdsale
asset
patent
age
n
p
p
p
e
c
r
l
j
u
r
n
l
f
n
g
e
e
n
dm
de
caroli
journal
manag
tabl
return
asset
market
book
regress
result
variabl
techcomp
imit
adsal
approv
rdsale
asset
patent
age
model
lag
model
p
p
p
model
lag
model
activ
adsal
neg
relationship
age
asset
rdsale
impli
older
larger
spend
less
advertis
sale
invers
relationship
among
adsal
rdsale
suggest
spend
research
develop
spend
less
advertis
tabl
show
regress
result
four
model
use
roa
depend
variabl
consist
result
across
model
techcomp
imit
support
hypothesi
techcomp
posit
imit
neg
support
hypothesi
hypothesi
support
adsal
hypothesi
support
lag
model
approv
posit
control
variabl
asset
rdsale
posit
model
age
neg
lag
model
model
show
regress
result
mkbk
depend
variabl
contrari
model
differ
result
particularli
techcomp
model
relationship
techcomp
mkbk
howev
model
neg
relationship
techcomp
mkbk
suggest
build
knowledg
advers
affect
futur
cash
support
hypothesi
consist
result
found
model
imit
neg
mkbk
adsal
posit
model
support
hypothesi
hypothesi
also
support
approv
posit
respect
control
variabl
asset
posit
model
rdsale
directli
relat
mkbk
model
final
patent
posit
model
skill
term
prevent
knowledg
appropri
discuss
despit
theoret
support
relationship
among
technolog
compet
perform
empir
result
studi
technolog
compet
posit
impact
return
asset
neg
effect
market
book
valu
lag
model
return
asset
return
invest
measur
result
suggest
dm
de
caroli
journal
manag
short
term
build
prior
stock
knowledg
may
superior
strategi
howev
futur
cash
evidenc
market
book
valu
strategi
build
knowledg
stock
account
unpredict
build
knowledg
could
indic
develop
core
rigid
leonardbarton
market
see
shortcom
implic
reli
compet
well
selfcit
demand
relianc
rather
develop
new
compet
damag
perform
could
lead
ignor
extern
develop
may
crucial
futur
competit
advantag
particularli
environ
character
rapid
technolog
advanc
result
highlight
controversi
appropri
perform
measur
strategi
literatur
also
speak
challeng
face
manag
make
strateg
decis
build
knowledg
may
short
term
market
view
view
strategi
rout
competit
advantag
relianc
compet
carri
day
futur
evidenc
invers
relationship
technolog
compet
market
book
valu
may
also
seen
tendenc
persist
current
trajectori
continu
establish
behavior
pattern
sull
sull
suggest
compani
becom
stuck
mode
think
work
initi
brought
success
environ
chang
may
unabl
incap
adapt
predict
neg
relationship
imit
perform
support
model
quit
result
given
magnitud
imit
concept
resourcebas
view
provid
strong
evid
competit
advantag
dilut
quickli
draw
technolog
knowledg
market
compet
posit
relat
market
book
valu
return
asset
impli
develop
market
compet
necessari
expens
immedi
contribut
account
return
may
fact
contribut
futur
valu
regulatori
compet
posit
one
regress
model
import
cultiv
effect
relationship
government
bodi
pharmaceut
industri
regulatori
compet
valu
asset
develop
time
contribut
perform
total
number
patent
posit
market
book
regress
model
consist
recent
prior
literatur
deng
et
al
hall
relationship
patent
activ
market
valu
organiz
ecolog
address
repercuss
age
organiz
innov
consensu
literatur
whether
repercuss
posit
neg
term
perform
sorensen
stuart
analysi
seem
suggest
market
agnost
age
age
neg
roa
impli
get
older
return
current
invest
shrink
final
research
develop
intens
directli
relat
perform
model
mention
earlier
prior
theoret
empir
literatur
inconsist
impact
research
invest
organiz
perform
extent
result
exhibit
inconsist
dm
de
caroli
journal
manag
overal
seem
suggest
compet
better
predictor
market
measur
perform
seem
squar
well
previou
studi
use
patent
data
deng
et
al
market
measur
perform
also
impli
market
incorpor
affect
stock
posit
evalu
futur
perform
futur
research
addit
question
studi
address
result
suggest
sever
new
direct
futur
research
articl
use
patent
citat
data
teas
extent
built
upon
innov
activ
futur
research
might
seek
way
measur
phenomena
build
knowledg
exampl
compet
could
develop
combin
intern
extern
learn
recombin
intern
knowledg
acquisit
extern
knowledg
incorpor
measur
repres
differ
dimens
technolog
compet
may
increas
understand
technolog
compet
impact
perform
howev
measur
knowledg
build
task
anoth
avenu
research
explor
intrigu
possibl
whose
innov
imit
may
fact
learn
imit
word
may
abl
enhanc
knowledg
learn
other
done
attempt
imit
scholarli
examin
imit
knowledg
may
impact
origin
knowledg
would
provid
tremend
insight
strategi
learn
technolog
area
studi
propos
measur
imit
central
construct
resourcebas
view
level
use
imit
measur
step
spur
futur
research
interest
operation
construct
examin
relationship
perform
relat
research
could
investig
tri
prevent
imit
protect
knowledg
appropri
skill
unto
examin
way
would
interest
avenu
research
anoth
avenu
futur
research
area
gener
altern
measur
market
compet
regulatori
compet
market
compet
strateg
import
pharmaceut
mani
industri
creation
measur
construct
would
great
contribut
area
similarli
regulatori
compet
abil
deal
effect
success
govern
agenc
critic
strateg
compet
mani
industri
commun
work
govern
agenc
compani
gain
certain
reput
adroit
inept
area
incorpor
impact
reput
directli
measur
regulatori
compet
might
shed
light
relationship
regulatori
compet
perform
final
fundament
issu
innov
daytoday
execut
busi
process
matter
perform
highlight
studi
market
book
model
execut
variabl
market
regulatori
compet
directli
relat
perform
roa
model
technolog
compet
dm
de
caroli
journal
manag
compet
variabl
directli
perform
futur
research
could
explor
possibl
practic
implic
gener
interest
manageri
implic
first
result
suggest
accumul
knowledg
alway
lead
competit
advantag
fact
result
actual
suggest
relianc
compet
harm
perform
long
run
technolog
dynam
industri
acquisit
incorpor
new
knowledg
critic
short
long
term
competit
advantag
evidenc
compani
challeng
simultan
learn
exploit
current
compet
alloc
resourc
develop
new
one
respect
pharmaceut
industri
rapid
advanc
biotechnolog
necessit
quick
learn
new
compet
establish
pharmaceut
second
challeng
pharmaceut
industri
respect
imit
innov
doubleedg
sword
pharmaceut
patent
protect
yet
reveal
knowledg
despit
fact
knowledg
build
critic
imit
knowledg
detriment
competitor
may
imit
approv
upon
innov
creat
new
knowledg
techniqu
product
underpin
manageri
imper
monitor
incorpor
technolog
develop
continu
gener
innov
improv
skill
term
prevent
knowledg
appropri
limit
interpret
subsequ
discuss
must
consid
context
limit
investig
focus
one
industri
lack
generaliz
howev
homogen
sampl
industri
disturb
held
constant
deeper
insight
effect
compet
imit
perform
would
obtain
examin
variabl
differ
industri
data
cover
select
time
period
longer
time
frame
may
shed
light
robust
hypothes
relationship
case
citat
made
patent
may
declin
later
year
enough
time
cite
limit
recogn
interpret
regress
result
moreov
patent
data
use
studi
limit
first
unabl
differenti
product
process
patent
also
patent
categori
may
exist
systemat
differ
patent
citat
among
differ
type
patent
second
limit
particular
patent
data
set
inabl
identifi
licens
acquir
patent
implic
term
build
stock
knowledg
conclus
articl
open
quot
prahalad
hamel
suggest
develop
new
compet
easi
unlik
simpli
get
one
train
saunter
onto
anoth
implicit
analog
fact
accumul
dm
de
caroli
journal
manag
expertis
take
time
acquir
also
take
time
transform
empir
result
highlight
jeopardi
inher
acquir
compet
import
new
learn
empir
also
provid
evid
neg
relationship
competitor
imit
knowledg
perform
final
result
suggest
perform
affect
compet
market
regulatori
hope
result
present
stimul
new
resourcebas
research
relationship
compet
imit
perform
industri
context
acknowledg
wish
thank
saad
anbari
continu
assist
project
would
also
like
thank
g
steven
mcmillan
mahesh
joshi
frank
linnehan
three
anonym
review
help
comment
earlier
draft
articl
refer
allen
lee
tushman
r
perform
function
intern
commun
project
manag
natur
work
ieee
transact
engin
manag
amit
r
schoemak
p
j
strateg
asset
organiz
rent
strateg
manag
journal
andrew
k
r
concept
corpor
strategi
homewood
dow
jonesirwin
barney
j
b
organiz
cultur
sourc
sustain
competit
advantag
academi
manag
review
barney
j
firm
resourc
sustain
competit
advantag
journal
manag
barney
j
resourcebas
use
perspect
strateg
manag
research
ye
academi
manag
review
betti
r
perform
differ
relat
unrel
strateg
manag
journal
betti
r
prahalad
c
domin
logic
new
linkag
divers
perform
strateg
manag
journal
bierli
p
chakrabarti
gener
knowledg
strategi
us
pharmaceut
industri
strateg
manag
journal
bogner
w
c
thoma
h
core
compet
competit
advantag
model
illustr
evid
pharmaceut
industri
g
hamel
heen
ed
compet
base
competit
chichest
wiley
campbel
r
niev
l
technolog
indic
base
patent
data
case
catalyt
convert
phase
report
design
demonstr
battel
northwest
laboratori
carpent
c
narin
f
valid
studi
patent
citat
indic
scienc
foreign
depend
world
patent
inform
chatterje
wernerfelt
link
resourc
type
theori
evid
strateg
manag
journal
chauvin
k
hirschey
advertis
r
expenditur
market
valu
financi
manag
cockburn
grilich
z
industri
effect
appropri
measur
stock
valuat
r
patent
aea
paper
proceed
dm
de
caroli
journal
manag
cohen
w
levinth
absorpt
capac
new
perspect
learn
innov
administr
scienc
quarterli
colli
resourcebas
analysi
global
competit
case
ball
bear
industri
strateg
manag
journal
cool
k
schendel
strateg
group
format
perform
case
us
pharmaceut
industri
manag
scienc
cool
k
schendel
perform
differ
among
strateg
group
member
strateg
manag
journal
day
g
capabl
marketdriven
organ
journal
market
de
caroli
deed
impact
stock
organiz
knowledg
perform
empir
investig
biotechnolog
industri
strateg
manag
journal
deng
z
lev
b
narin
f
scienc
technolog
predictor
stock
perform
financi
analyst
journal
dierickx
cool
k
asset
stock
accumul
sustain
competit
advantag
manag
scienc
dosi
g
technolog
paradigm
technolog
trajectori
research
polici
economist
bull
pill
patent
economist
fiol
lyle
organiz
learn
academi
manag
review
grabowski
h
g
vernon
new
look
return
risk
pharmaceut
r
manag
scienc
grant
r
b
resourcebas
theori
competit
advantag
implic
strategi
formul
california
manag
review
grave
langowitz
n
innov
product
return
scale
pharmaceut
industri
strateg
manag
journal
hall
b
innov
market
valu
work
paper
oxford
univers
hall
b
jaff
trajtenberg
market
valu
patent
citat
look
work
paper
univers
california
berkeley
harrison
j
hitt
hoskisson
r
ireland
r
synergi
post
acquisit
perform
differ
versu
similar
resourc
alloc
journal
manag
hausman
j
hall
b
grilich
z
econometr
model
count
data
applic
relationship
econometrica
henderson
r
cockburn
measur
compet
explor
effect
pharmaceut
research
strateg
manag
journal
henderson
r
cockburn
scale
scope
spillov
determin
research
product
drug
discoveri
rand
journal
econom
hill
c
hansen
g
longitudin
studi
caus
consequ
chang
us
pharmaceut
industri
strateg
manag
journal
hill
c
snell
extern
control
corpor
strategi
perform
research
intens
industri
strateg
manag
journal
hitt
ireland
r
corpor
distinct
compet
strategi
industri
perform
strateg
manag
journal
hitt
ireland
r
palia
k
industri
grand
strategi
function
import
moder
effect
technolog
uncertainti
academi
manag
journal
hitt
ireland
r
stadter
g
function
import
compani
perform
moder
effect
grand
strategi
industri
type
strateg
manag
journal
hunt
morgan
r
compar
advantag
theori
competit
journal
market
jensen
e
research
expenditur
discoveri
new
drug
journal
industri
econom
jose
nichol
l
steven
j
winter
contribut
promot
r
valu
multiproduct
financi
manag
katz
r
ed
manag
profession
innov
organ
collect
read
new
york
harper
busi
kogut
b
zander
u
knowledg
combin
capabl
replic
technolog
organ
scienc
dm
de
caroli
journal
manag
langreth
r
septemb
new
techniqu
discov
medicin
take
hold
wall
street
journal
lecraw
j
strategi
perform
journal
industri
econom
leonardbarton
core
capabl
core
rigid
paradox
manag
new
product
develop
strateg
manag
journal
summer
special
issu
leonardbarton
wellspr
knowledg
boston
harvard
busi
school
press
lev
b
sougianni
penetr
booktomarket
black
box
r
effect
journal
busi
financ
account
levin
r
et
al
survey
research
r
appropri
technolog
opportun
research
paper
yale
univers
lustgarten
thomadki
mobil
barrier
q
journal
busi
markid
c
williamson
p
j
relat
core
compet
corpor
perform
strateg
manag
journal
markid
c
williamson
p
corpor
organiz
structur
resourcebas
view
academi
manag
journal
mcclean
w
round
k
research
product
innov
australian
manufactur
industri
journal
industri
econom
medad
news
septemb
greater
expens
fewer
reward
miller
shamsi
j
resourcebas
view
two
environ
hollywood
studio
academi
manag
journal
mooreman
c
slotegraaf
r
conting
valu
complementari
capabl
product
develop
journal
market
research
morck
r
shleifer
vishni
r
manag
ownership
market
valuat
empir
analysi
journal
financi
econom
mizruchi
stearn
l
longitudin
studi
format
interlock
director
administr
scienc
quarterli
mueller
dynam
compani
intern
comparison
cambridg
cambridg
univers
press
narin
f
rose
olivastro
patent
citat
analysi
new
valid
studi
linkag
statist
f
j
van
raan
j
nederof
h
f
mo
ed
proceed
leiden
workshop
scienc
technolog
indic
use
scienc
polici
role
scienc
studi
nelson
r
winter
evolutionari
theori
econom
chang
cambridg
harvard
univers
press
nonaka
dynam
theori
organiz
knowledg
creation
organiz
scienc
park
r
w
estim
system
regress
equat
disturb
serial
contemporan
correl
journal
american
statist
associ
pisano
g
develop
factori
unlock
potenti
process
innov
boston
harvard
busi
school
press
prahalad
c
k
hamel
g
core
compet
corpor
harvard
busi
review
priem
r
butler
j
resourcebas
view
use
perspect
strateg
manag
research
academi
manag
review
reed
r
defillippi
r
j
causal
ambigu
barrier
imit
sustain
competit
advantag
academi
manag
review
robin
j
wiersema
f
resourcebas
approach
multibusi
empir
analysi
portfolio
interrelationship
corpor
perform
strateg
manag
journal
scherer
f
firm
size
market
structur
opportun
output
patent
invent
american
econom
review
selznick
p
leadership
administr
new
york
harper
snow
c
c
hrebiniak
l
g
strategi
distinct
compet
organiz
perform
administr
scienc
quarterli
sorensen
j
b
stuart
e
age
obsolesc
organiz
innov
administr
scienc
quarterli
dm
de
caroli
journal
manag
stearn
l
mizruchi
board
composit
corpor
impact
institut
represent
borrow
academi
manag
journal
sull
good
compani
go
bad
harvard
busi
review
tanouy
e
langreth
r
patent
expir
big
prescript
drug
industri
quak
wall
street
journal
teec
technolog
innov
implic
integr
collabor
licens
public
polici
research
polici
teec
pisano
g
shuen
dynam
capabl
strateg
manag
strateg
manag
journal
thoma
l
g
regul
size
fda
impact
innov
rand
journal
econom
trajtenberg
penni
quot
patent
citat
time
valu
innov
rand
journal
econom
tushman
anderson
p
technolog
discontinu
organiz
environ
administr
scienc
quarterli
wernerfelt
b
resourcebas
view
strateg
manag
journal
donna
mari
de
caroli
associ
professor
manag
drexel
univers
research
interest
entrepreneurship
technolog
innov
manag
focus
work
pharmaceuticalbiotechnolog
industri
publish
strateg
manag
journal
journal
busi
ventur
entrepreneurship
theori
practic
